Physician intervention for medication reduction in a nursing home: the polypharmacy outcomes project
- PMID: 21450207
- PMCID: PMC3102122
- DOI: 10.1016/j.jamda.2010.08.013
Physician intervention for medication reduction in a nursing home: the polypharmacy outcomes project
Abstract
Objective: To examine the effects of a medication review project by geriatricians and geriatric medicine fellows on polypharmacy in a teaching nursing home.
Design: Quality improvement intervention study
Setting: Long-term care facility in Honolulu, HI PARTICIPANTS: Seventy-four patients with the Minimum Data Set quality indicator criteria of polypharmacy (9 or more medications).
Intervention: Geriatric medicine fellows and faculty reviewed each patient's medication list, consulted the updated Beers Criteria and Epocrates online drug-drug interaction program, and recommended medication changes to the patients' primary care physicians.
Measurements: Descriptive statistics, including means, standard deviations, and sums of variables were obtained for the number of medications in the following categories: total number, scheduled, pro re nata, high risk, contraindicated, with potential drug-drug interactions, and with no indication.
Results: Of 160 patients residing in a nursing home, 74 were on 9 or more medications. After the intervention, the mean number of medications per patient in the following categories decreased significantly: total number (16.64 to 15.54, P < .001), scheduled (11.3 to 10.99, P < .001), pro re nata (5.33 to 4.56, P < .001), high risk (0.94 to 0.73, P < .001), contraindicated (0.29 to 0.13, P = .004), with potential drug-drug interactions (6.1 to 4.83, P < .001), and with no indication (3.34 to 3.29, P = .045).
Conclusion: Polypharmacy in long-term care is prevalent and can lead to increased adverse effects and potentially inappropriate prescriptions. This study demonstrates an effective geriatrician-led intervention that both reduced polypharmacy and provided core competency training for geriatric medicine fellows.
Copyright © 2011 American Medical Directors Association. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Reducing cost by reducing polypharmacy: the polypharmacy outcomes project.J Am Med Dir Assoc. 2012 Nov;13(9):818.e11-5. doi: 10.1016/j.jamda.2012.07.019. Epub 2012 Sep 5. J Am Med Dir Assoc. 2012. PMID: 22959733 Free PMC article.
-
Effect of Clinical Geriatric Assessments and Collaborative Medication Reviews by Geriatrician and Family Physician for Improving Health-Related Quality of Life in Home-Dwelling Older Patients Receiving Polypharmacy: A Cluster Randomized Clinical Trial.JAMA Intern Med. 2020 Feb 1;180(2):181-189. doi: 10.1001/jamainternmed.2019.5096. JAMA Intern Med. 2020. PMID: 31617562 Free PMC article. Clinical Trial.
-
Combining quality improvement and geriatrics training: the nursing home polypharmacy outcomes project.Gerontol Geriatr Educ. 2014;35(4):395-408. doi: 10.1080/02701960.2014.907159. Epub 2014 Jun 5. Gerontol Geriatr Educ. 2014. PMID: 24829040 Free PMC article.
-
Pro Re Nata Drug Use in Nursing Home Residents: A Systematic Review.J Am Med Dir Assoc. 2019 Mar;20(3):287-293.e7. doi: 10.1016/j.jamda.2018.10.024. Epub 2018 Dec 11. J Am Med Dir Assoc. 2019. PMID: 30551948
-
[Polypharmacy in nursing homes: options to improve drug therapy safety].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023 May;66(5):530-539. doi: 10.1007/s00103-023-03694-4. Epub 2023 Apr 12. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023. PMID: 37042988 Review. German.
Cited by
-
Frailty consensus: a call to action.J Am Med Dir Assoc. 2013 Jun;14(6):392-7. doi: 10.1016/j.jamda.2013.03.022. J Am Med Dir Assoc. 2013. PMID: 23764209 Free PMC article.
-
Polypharmacy in Polish Older Adult Population-A Cross-Sectional Study: Results of the PolSenior Project.Int J Environ Res Public Health. 2022 Jan 18;19(3):1030. doi: 10.3390/ijerph19031030. Int J Environ Res Public Health. 2022. PMID: 35162054 Free PMC article.
-
The composition of polypharmacy: A register-based study of Swedes aged 75 years and older.PLoS One. 2018 Mar 29;13(3):e0194892. doi: 10.1371/journal.pone.0194892. eCollection 2018. PLoS One. 2018. PMID: 29596512 Free PMC article.
-
Polypharmacy reviews among elderly populations project: assessing needs in patient-provider communication.Hawaii J Med Public Health. 2013 Jan;72(1):15-22. Hawaii J Med Public Health. 2013. PMID: 23386990 Free PMC article.
-
Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders.J Affect Disord. 2019 Jun 1;252:450-457. doi: 10.1016/j.jad.2019.04.018. Epub 2019 Apr 8. J Affect Disord. 2019. PMID: 31004825 Free PMC article.
References
-
- Nguyen JK, Fouts MM, Kotabe SE, Lo E. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother. 2006;4(1):36–41. - PubMed
-
- Field TS, Gurwitz JH, Avorn J, et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med. 2001;161:1629–1634. - PubMed
-
- Gill SS, Misiaszek BC, Brymer C. Improving prescribing in the elderly: A study in the long-term care setting. Can J Clin Pharmacol. 2001;8:78–83. - PubMed
-
- Finkers F, Maring JG, Boersma F, Taxis K. A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. J Clin Pharm Ther. 2007;32:469–476. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical